GHAPPcast Part 3: Provider & Patient Support
In this episode of GHAPPcast, Jordan Mayberry, a PA-C at UT Southwestern in Dallas, Texas, and Patrick Horne, a nurse practitioner from the University of Florida, dive deep into the support strategies...
29 Jan 202510min
FAQ: Is there a correlation of myeloid cells expressing CD64 and endoscopy disease severity?
Thank you to Johnson & Johnson for your support of this FAQ Video Module.In this video module, Amy Stewart, NP, from Capital Digestive Care, in Washington, D.C., explores the potential correlation bet...
28 Jan 20251min
GHAPPcast Part 2: Diagnosis and Management
In this insightful GHAPPcast podcast, Patrick Horne, a nurse practitioner at the University of Florida, joins Jordan Mayberry, a physician assistant at UT Southwestern, to discuss the diagnosis and ma...
24 Jan 202512min
FAQ: Why is binding CD64+ important when discussing IL23 directed therapy?
Thank you to Johnson & Johnson for your support of this FAQ Video Module.Join Sarah Enslin, PA-C, from the University of Rochester Medical Center, as she explores the latest advancements in CD64-posit...
23 Jan 20252min
GHAPPcast Part 1: Understanding Chronic Liver Disease and Cirrhosis
In this GHAPP podcast episode, Jordan Mayberry, PA-C, and Patrick Horne, NP, dive deep into the complexities of chronic liver disease and its progression to cirrhosis. Drawing on over 11 years of expe...
22 Jan 202510min
Medication Review: How is guselkumab dosed in IBD?
Thank you to Johnson & Johnson for your support of this Medication Review Video Module.In this medication review video module, Anne Feldman, NP, from the Cleveland Clinic Foundation, provides an in-de...
21 Jan 20253min
GHAPPcast: CD64+ Binding: Description, Relevance, and Potential Clinical Implications
Thank you to Johnson & Johnson for your support of this GHAPPcast episode.In this insightful episode of GHAPPcast, the official podcast of the Gastroenterology and Hepatology Advanced Practice Provide...
16 Jan 202511min
FAQ: Provide immunologic rationale for IL23 directed therapy in IBD(+ general overview of Guselkumab MOA)
Thank you to Johnson & Johnson for your support of this FAQ Video Module.In this informative FAQ video module, Sarah Enslin, a physician assistant at the University of Rochester Medical Center, discus...
14 Jan 20252min
